[The clinico-laboratory evaluation of the efficacy of Ciprobai and Cifran in treating the exacerbations of chronic pyelonephritis in patients with urolithiasis].
Explore the source record for details and available documents.
Adult↗
Biomedical subjects
V N Nasonov
Publications and source records attributed to V N Nasonov.
[Ciprofloxacin in the treatment of chronic bacterial prostatitis].
17 exacerbation and 13 latent CBP cases received ciprofloxacin in a dose 500 mg twice a day orally for 6-34 days. At pretreatment microbiological investigation of the prostatic juice 49 cultures of 7 microorganism species were isolated (12 cases of monoculture, 18 cases of 2-component associations). S. epidermidis and E. faecalis occurred more frequently (in 29.4 and 25%, respectively). Ciprofloxacin was highly active against all the isolated agents and by the number of sensitive to it strains proved superior to control antimicrobial drugs. Good and satisfactory treatment outcomes were achieved in 76.8% of patients. Side effects recorded in 8 patients (26.6%) caused the drug undue discontinuation in 1 patient only.
Adult↗